Clinical Trial Update: Development and Evaluation of a New Palliative Care Service for People Severely Affected With Multiple Sclerosis (MS) [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating a new palliative care service for people severely affected by multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: King's College London | Conditions: Multiple Sclerosis | Phase 1, Phase 2 | Status: COMPLETED